Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 30 for “"SMARCA4"”.
-
SMARCA4/BRG1-Inactivating Mutations as Potential Predictive Markers for Aurora Kinase A-Targeted Therapy in NSCLCs
SMARCA4 encodes a catalytic subunit of the SWI/SNF chromatin remodeling complex, BRG1. Frequent occurrence of SMARCA4/BRG1-inactivating mutations and their mutually exclusive nature from EGFR and ALK lesions create one of the largest subsets of Non-Small Cell Lung Cancers (NSCLCs). Since these …
-
Tumorbiologische Bedeutung von SMARCA4 und SMARCE1 im Magenkarzinom, Korrelation mit ARID1A, Mikrosatellitenstatus sowie SMARCE1/ERBB2 Ko-Amplifikation
… die folgende Hypothesen überprüft werden: (1) SMARCA4 und SMARCE1 zeigen unterschiedlichen Arten der Expression sowie intratumorale Heterogenität beim Magenkarzinom. (2) Die Expression von SMARCA4 und SMARCE1 korreliert mit klinisch-pathologi schen Patientencharakteristika. (3) Es liegt eine …
-
The Genomic Landscape and Prognostic Impact of KRAS, STK11, and SMARCA4 Mutations and Co-Mutations on Survival Outcomes in Non-Small Cell Lung Cancer
… regulator of chromatin, subfamily A, member 4 (SMARCA4) mutations and co-mutations have been increasingly recognized for their potential prognostic significance. However, clear knowledge gaps remain regarding which treatments should be selected for patients who present clinically with KRAS/STK11 …
-
Structure and function of chromatin remodelling ATPases and their dysfunction in human diseases
… top 200 tumour suppressor genes, particularly SMARCA4, the Snf2 ATPase subunit of the human SWI/SNF complex. Most mutations in Snf2 proteins found in tumours are missense mutations; however, the mode of action through which these mutations may cause disease remains uncertain. Here, an analysis …
-
Establishment and analysis of patient-specific Group 3 medulloblastoma mouse models
… Among all the putative oncosuppressors, SMARCA4 is the most frequently mutated. Indeed, co-expression of SMARCA4 with Otx2 and cMYC is able to block tumorigenesis, through regulation of CDKN2B and CRABP1 expression. Interestingly, patient-specific SMARCA4T910M mutant is able to block …
-
The induction of an antiviral state by MxA requires the presence of the ATPases SMARCA2 and SMARCA4, which can be inactivated by caspase-mediated cleavage
… activity of MxA. SMARCA2 and its homolog SMARCA4 are mutually exclusive ATPase subunits residing within the multi-subunit chromatin-remodeling BAF-complex and localized in the cell nucleus, however, A549 cells do not express SMARCA4 but only SMARCA2. Similar to the known function of …
-
The role of BAF complexes in regulating transcription factor occupancy
… with tumour suppressor subunits ARID1A and SMARCA4/2 being the most commonly mutated among them, investigating the context- specific effects of their mutations on transcription factor occupancy can give us much insight into the ensuing transcriptional changes that lead into oncogenic …
-
Exploring genetic alterations and protein marker expression in cancer: investigating ARID1A and SMARCA4 knock-outs in colorectal cancer and evaluating histological markers for targeted therapy in ovarian cancer
This dissertation presents two distinct yet connected research projects focused on the alteration and evaluation of DNA and protein expression in common cancers, both of which are subjects of ongoing research into their mechanisms and potential therapeutic advancements. Colorectal cancer, one of …
-
Avaliação de alvos moleculares envolvidos na resistência tumoral de sarcoma de Ewing
… um conjunto de genes (CCAR1, TUBA1A, POLDIP2, SMARCA4 e SMARCB1) a partir da mineração da literatura em resistência tumoral para duas drogas utilizadas na terapia de ES, doxorrubicina e vincristina. Descrevemos a expressão de cada gene selecionado antes e após as linhagens SK-ES-1 serem …
-
Chromatin Deregulation in Cancer
… remodeler by reactivating the BAF complex member SMARCA4 in a SMARCA4-null lung adenocarcinoma cell line. We observed low affinity TF binding sites were preferentially affected by SMARCA4 reactivation and the domain level organization of such sites directs the effects of global chromatin …
-
Investigating molecular mechanisms of dedifferentiation and mutations in dedifferentiated endometrial carcinoma
… Multiple SWI/SNF members were studied, including SMARCA4, ARID1A, ARID1B, SMARCB1, and SMARCA2 to determine the extent of the abnormality of SWI/SNF components and p53 in DDEC/UEC. The prognostic value of these mutations was also assessed. I found that SMARCA4/A2 dual loss, ARID1A/1B dual loss, …
-
Small cell carcinoma of the ovary, hypercalcemic type : model development and preclinical drug testing
… have demonstrated that concurrent dual loss of SMARCA4/A2, the two only ATPase of the SWI/SNF chromatin-remodeling complex, occurs in more than 90% SCCOHT cases, which opens the opportunity for developing targeted therapeutics for treating SCCOHT. One major challenge for preclinical studies is …
-
Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer
… in dephorphorylation of the SWI/SNF protein SMARCA4 and represses HP1α expression, both of which contribute to gene reactivation. Based on gene activation, we developed the highly selective and potent CDK9 inhibitor MC180295 (IC50 =5nM) that has broad anti-cancer activity in-vitro and is …
-
Transcriptome Approach for Identifying Potential Biomarkers for Endocrine Disruption due to Crude Oil Exposure using Killifish (Fundulus Heteroclitus).
… acetyltransferase p300, SIRT1; Sirtuin 1 and SMARCA4; Transcription activator BRG1), impaired spermatogenesis (SMARCA4 and DNAJA1; heat shock protein family (Hsp40) member A1,) and suppressed androgen receptor transcriptional activation (HDAC6; (Histone deacetylase 6 and PTGES3; Prostaglandin …
-
Characterization of epithelioid sarcoma using massively parallel DNA and RNA sequencing and in vitro models
… we explore two approaches, namely EZH2 and SMARCA4 inhibitions, to specifically exploit this abnormality and suggest novel therapeutic options.
-
The leukocyte complexity and mutational landscape of periampullary adenocarcinoma. Morphology matters.
… I-typetumours. in patients with PB-type tumours, SMARCA4 mutation was a negative prognostic factor in patients notreceiving adjuvant chemotherapy and there was a positive interaction between high expression of BRG1, theprotein encoded by SMARCA4, and adjuvant chemotherapy in relation to OS. Paper …
-
EXPLORING COREST INHIBITOR, CORIN, AS A NOVEL STRATEGY FOR TARGETED THERAPY IN RHABDOID TUMORS
… characterized by inactivation of SMARCB1 or SMARCA4, leading to epigenetic dysregulation and poor clinical outcomes. Current therapies yield limited efficacy, highlighting an urgent need for novel treatment strategies. This study investigates the therapeutic potential of corin, a dual …
-
The role of the SWI/SNF ATP dependent chromatin remodelling complex in the regulation of the human hair follicle cell proliferation and control of the human cutaneous wound healing
… in human epidermis and that siRNA mediated SMARCA4 gene suppression in primary human keratinocyte monolayers defined the requirements of BRG1 for wound closure through control of cell migration, but not proliferation. In summary, this data revealed a diverse SWI/SNF complex subunit …
-
Identification of critical hypoxia-induced factors in prostate cancer treatment resistance
… methyltransferases, including KMT2C, KMT2D and SMARCA4, were significantly depleted (FDR < 0.05), indicating enhancer-mediated transcriptional dependencies. Functional validation demonstrated that silencing KMT2C and KMT2D reduced survival by 40% under hypoxia but not normoxia. RNA-seq analysis …
Page 1 of 2